A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice
- 27 March 2007
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 80 (16), 1525-1538
- https://doi.org/10.1016/j.lfs.2007.01.029
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Neuritic regeneration and synaptic reconstruction induced by withanolide ABritish Journal of Pharmacology, 2005
- Withaferin A is a potent inhibitor of angiogenesisAngiogenesis, 2004
- Distinct Role of CD80 and CD86 in the Regulation of the Activation of B Cell and B Cell LymphomaOnline Journal of Public Health Informatics, 2002
- Interleukin-10 and the Interleukin-10 ReceptorAnnual Review of Immunology, 2001
- Immunomodulatory Properties of Interferon‐γ: An UpdateaAnnals of the New York Academy of Sciences, 1998
- Antitumor and Radiosensitizing Effects of Withaferin a on Mouse Ehrlich Ascites Carcinoma in vivoActa Oncologica, 1996
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- Lymphokine Control of In Vivo Immunoglobulin Isotype SelectionAnnual Review of Immunology, 1990
- The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.The Journal of Experimental Medicine, 1988
- Pharmacological Studies on Leaves ofWithania somniferaPlanta Medica, 1986